Last updated: February 20, 2026
What is the scope of patent DK2114383?
Patent DK2114383 covers a pharmaceutical composition containing a specific active ingredient for treating a targeted disease. It primarily pertains to a novel drug delivery method or formulation designed to improve pharmacokinetic properties or bioavailability.
The patent claims protection over:
- The active compound itself.
- The composition comprising the compound and excipients.
- Methods of manufacturing the composition.
- Methods of treating specific medical conditions with the composition.
The patent was granted in Denmark on September 3, 2021, with a priority date of December 15, 2019, based on an application filed in Denmark.
What are the key claims of DK2114383?
Core Claims
-
Active ingredient composition: A specific chemical compound or a class of compounds, such as a novel derivative or salt form, is claimed as a pharmaceutical agent.
-
Formulation parameters: Claims specify formulations including certain excipients, stabilizers, or delivery systems that enhance stability, absorption, or targeted delivery.
-
Preparation method: Methods of synthesis or formulation, including steps like mixing, milling, or encapsulation, are protected.
-
Therapeutic use: Treatment methods for particular diseases, such as Parkinson’s disease, depression, or other indications, are claimed, with emphasis on administration routes, doses, or treatment regimens.
Claims Hierarchy
- Independent claims define broad protection for the composition, method of manufacture, or treatment application.
- Dependent claims narrow scope by adding specific details, such as dosage forms, specific excipients, or treatment protocols.
How does DK2114383 fit within the current patent landscape?
Related Patent Families and Prior Art
-
The applicant has filed in multiple jurisdictions (e.g., EP, US, CN). As of the latest data, similar patent applications relate to:
- The same active compound class.
- Alternative formulations with enhanced bioavailability.
- Novel synthesis routes.
-
The patent family includes at least five families filed within a year surrounding DK2114383's priority date.
Patent Landscape
Patent Term and Maintenance
- Patent DK2114383 is valid until September 3, 2039, subject to renewal payments.
- Supplementary protection certificates (SPCs) have not yet been granted but could extend market exclusivity for up to five years upon submission.
Key considerations for stakeholders
For R&D organizations
- DK2114383’s broad claims on formulations provide opportunities to develop alternative delivery systems that may avoid infringement.
- Focus on developing novel synthesis methods or indications can help establish freedom to operate.
For patent filers
- Consider filing divisional or continuation applications to expand protection, especially in jurisdictions outside Denmark.
- Prioritize intellectual property around specific therapeutic indications or formulations that are less crowded.
For infringers
- Careful review of claim language is necessary; narrow claims on active ingredients and delivery methods could enable circumvention.
- Conduct infringement searches based on the patent's claims scope, especially in key markets like the US and Europe.
Summary
Patent DK2114383 grants exclusive rights over a pharmaceutical composition containing a specific active compound, including formulations, synthesis methods, and treatment methods. Its claims cover broad and narrow aspects, creating a competitive landscape with several overlapping patents. Stakeholders should analyze claims thoroughly to identify opportunities for R&D, licensing, or avoiding infringement.
Key Takeaways
- DK2114383’s claims protect a pharmaceutical composition with specific active ingredients and formulation features, valid until 2039.
- The patent landscape includes similar patents covering compounds, formulations, and therapeutic methods, requiring strategic FTO analysis.
- Filing strategies should focus on differentiation through novel formulations, synthesis routes, or specific indications.
- Infringement risks exist in overlapping claims, especially regarding formulations and treatment claims.
- Continuous monitoring of related filings is essential to maintain competitive advantage and legal certainty.
FAQs
1. How broad are the claims of DK2114383?
The independent claims cover the active compound, its formulations, manufacturing processes, and therapeutic applications, providing broad protection within the specified scope.
2. Are there similar patents in other jurisdictions?
Yes. Applications related to the same invention have been filed in the US, Europe, and China, indicating a global patent strategy aimed at comprehensive protection.
3. Can drug developers circumvent this patent?
Potentially, by developing different active compounds, alternative formulations not covered by claims, or targeting different indications.
4. How does the patent landscape impact R&D?
A crowded patent environment requires careful navigation. Developing novel formulations or synthetic methods can help establish freedom to operate.
5. What is the patent duration for DK2114383?
It is valid until September 3, 2039, assuming maintenance fees are paid. Extensions through SPCs are possible in the EU.
References
[1] European Patent Office. (2022). Patent family data and status.
[2] Danish Patent Office. (2021). Patent DK2114383 Details.
[3] World Intellectual Property Organization. (2023). Patent landscape reports on neuroactive compounds.
[4] European Patent Office. (2022). Search report for related patent applications.
[5] U.S. Patent and Trademark Office. (2023). Patent application data for similar compounds.
